Wealthcare Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Wealthcare Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-309	Closed	-$31K	–	233
2015 Q3	$31K	Hold	309	–	–	﹤0.01%	107
2015 Q2	$38K	Hold	309	–	–	﹤0.01%	121
2015 Q1	$35K	Hold	309	–	–	﹤0.01%	316
2014 Q4	$31K	Hold	309	–	–	﹤0.01%	100
2014 Q3	$28K	Hold	309	–	–	﹤0.01%	102
2014 Q2	$26K	Hold	309	–	–	﹤0.01%	104
2014 Q1	$24K	Hold	309	–	–	﹤0.01%	103
2013 Q4	$23K	Hold	309	–	–	﹤0.01%	65
2013 Q3	$22K	Hold	309	–	–	﹤0.01%	63
2013 Q2	$18K	Buy	+309	New	+$17.9K	﹤0.01%	69

Other funds holding IBB

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wealthcare Capital Management's IBB Position: Q4 2015 in Review

Wealthcare Capital Management sold out of iShares Biotechnology ETF (IBB) in Q4 2015, closing a stake of 309 shares — an estimated $31K sold.

Wealthcare Capital Management first reported a position in IBB in Q2 2013 and held it in 10 quarters. The position peaked at $38K in Q2 2015. 432 funds tracked by Wall St. Rank hold IBB as of Q4 2015.

Wealthcare Capital Management reported no remaining iShares Biotechnology ETF position as of Q4 2015 after selling out during the quarter.
Wealthcare Capital Management sold 309 iShares Biotechnology ETF shares in Q4 2015, an estimated $31K.
Wealthcare Capital Management first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 10 quarters.
Wealthcare Capital Management's iShares Biotechnology ETF position peaked at $38K in Q2 2015.
432 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2015.

Based on Wealthcare Capital Management's 13F filing for Q4 2015, filed 13 Jan 2016.